İçeriğe geç
akaturk Akademik ölçüm
Giriş yap Kayıt ol

Akademisyen

FAHİR ÖZKALEMKAŞ

PROFESÖR

BURSA ULUDAĞ ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

Araştırma konuları OpenAlex
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Hematoloji (İç Hastalıkları)
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 137
YÖKSİS137 OpenAlex0
Proje 4
Kitap 2
Bildiri 111

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 85
h-indeks 11 Türkiye yüzdelik dilimi: 88 Üniversitesinde h-indekse göre 223. / 1.649
i10-indeks
12
Toplam atıf
385
Türkiye’de üst %14
Makale başına
4,5
FWCI
0,56
1,00 = dünya ortalaması
Dünyada üst %1
0
Dünyada üst %10
5

En çok atıf alan makaleleri

  1. İmatinib use during pregnancy and breast feeding a case report and review of the literature 2009 dünyada üst %10 80 atıf
  2. Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data 2023 dünyada üst %10 33 atıf
  3. A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia 2021 dünyada üst %10 23 atıf

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 66
  • Q1 16 %24,2
  • Q2 26 %39,4
  • Q3 21 %31,8
  • Q4 3 %4,5
WoS (JCR) 67
  • Q1 13 %19,4
  • Q2 16 %23,9
  • Q3 24 %35,8
  • Q4 14 %20,9
TR Index 46 makale
OpenAlex atıf yüzdelik
Üst %10
Üst %108
Ort. · n 110 %43,8
Diğer sayımlar

Scopus (SJR)

  • Özet hariç 64 Q1 14 Q2 26 Q3 21 Q4 3
  • YÖKSİS satırı 83

WoS (JCR)

  • Özet hariç 65 Q1 11 Q2 16 Q3 24 Q4 14
  • YÖKSİS satırı 84

TR Index

  • YÖKSİS satırı 53 makale

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

137makale

Yayını olan dergiler

65 dergi

Daralt

Scopus (SJR)
Q116 Q226 Q321 Q43
WoS (JCR)
Q113 Q216 Q324 Q414
TR Index
46makale

Makale listesi

  1. 2025 A comparison of the effect of three different comorbidity indices on overall survival in patients with chronic myeloid leukemia Therapeutic Advances in Hematology DOI 10.1177/20406207251323701 YÖKSİS SJR Q1 JCR Q2 OpenAlex 65.8%
  2. 2025 Viable and Functional: Long-Term −80 °C Cryopreservation Sustains CD34+ Integrity and Transplant Success Journal of Clinical Medicine DOI 10.3390/JCM14197032 YÖKSİS SJR Q2 JCR Q1 OpenAlex 76.0%
  3. 2025 Modified Endothelial Activation and Stress Index: A New Predictor for Survival Outcomes in Classical Hodgkin Lymphoma Treated with Doxorubicin-Bleomycin-Vinblastine-Dacarbazine-Based Therapy Diagnostics DOI 10.3390/diagnostics15020185 YÖKSİS SJR Q2 JCR Q1 OpenAlex üst %10 OpenAlex 97.7%
  4. 2025 Risk factors for mortality in febrile neutropenic patients treated with colistin Medicine DOI 10.1097/MD.0000000000044841 YÖKSİS SJR Q2 JCR Q2 OpenAlex 50.4%
  5. 2025 Shifting Paradigms in Antifungal Prophylaxis and Their Effects on Candidemia Outcomes in Hematological Malignancies: A 14-Year Experience from a Single Tertiary Center Journal of Fungi DOI 10.3390/jof11090630 YÖKSİS SJR Q1 JCR Q1 OpenAlex 21.3%
  6. 2025 Predicting Bleeding in AML-Associated DIC: Limitations of the ISTH Score and a Modified Approach Diagnostics DOI 10.3390/diagnostics15233053 YÖKSİS OpenAlex 84.2%
  7. 2025 Utilization and importance of timing of therapeutic plasma exchange in kidney transplantation: A single‐center experience Therapeutic Apheresis and Dialysis DOI 10.1111/1744-9987.70002 YÖKSİS SJR Q3 JCR Q3 OpenAlex 6.2%
  8. 2025 Comprehensive analysis of FLT3-mutated patients with acute myeloid leukemia with updated 2022 European LeukemiaNet recommendations: insights from the Turkish AML registry project BMC Cancer DOI 10.1186/s12885-025-14987-z YÖKSİS SJR Q2 JCR Q2 OpenAlex 74.8%
  9. 2025 Could PTH/Ca Ratio Serve as a New Marker for Evaluating Bone Metabolism in Hemophilia Patients? Diagnostics DOI 10.3390/diagnostics15050638 YÖKSİS OpenAlex 5.4%
  10. 2025 Prognostic Value of Inflammation and Nutrition-Based Scores in Low-Risk Myelodysplastic Syndrome: A Retrospective Cohort Study Journal of Clinical Medicine DOI 10.3390/jcm14134751 YÖKSİS SJR Q2 JCR Q1 OpenAlex 70.3%
  11. 2025 In-Hospital Mortality Among Hematological Malignancy Patients Undergoing Bronchoscopy for Suspected Invasive Pulmonary Aspergillosis: Focusing on Coinfections and Nodules on Chest CT Mycopathologia DOI 10.1007/s11046-025-01005-w YÖKSİS SJR Q1 JCR Q1 OpenAlex 24.6%
  12. 2025 Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group Journal of Clinical Medicine DOI 10.3390/jcm14196813 YÖKSİS SJR Q2 JCR Q1
  13. 2025 Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML Registry Journal of Clinical Medicine DOI 10.3390/jcm14207367 YÖKSİS SJR Q2 JCR Q1 OpenAlex 32.9%
  14. 2025 Clinical Manifestations, Treatment Characteristics and Clinical Outcome in Patients with Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in the Real-World Setting: An Interim Analysis of the Turkish aTTP Registry Turkish Journal of Hematology DOI 10.4274/tjh.galenos.2025.2025.0134 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 12.0%
  15. 2025 (PB2807) ASSESSMENT OF CHARACTERISTICS AND TREATMENT PATTERNS OF ADULT PATIENTS WITH ACQUIRED APLASTIC ANAEMIA IN TURKIYE (PLANE-TR STUDY) HemaSphere DOI 10.1002/hem3.70153 YÖKSİS SJR Q1 JCR Q1
  16. 2025 SARS-CoV-2 Enfeksiyonunda Hastalık Şiddetine Göre İndolamin 2,3-Dioksijenaz Enziminin İncelenmesi Mikrobiyoloji Bulteni DOI 10.5578/mb.2025131 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 5.0%
  17. 2025 Predictive value of TGF-β1 and SMAD-7 expression at diagnosis for treatment response in low-risk myelodysplastic syndrome Biomolecules and Biomedicine DOI 10.17305/bb.2025.11564 YÖKSİS SJR Q2 JCR Q3 OpenAlex 78.9%
  18. 2025 Comparative Analysis and Validation of the IMPEDED VTE, IMPEDE VTE, and SAVED Risk Models in Predicting Venous Thromboembolism in Multiple Myeloma Patients: A Retrospective Study in Türkiye Diagnostics DOI https://www.mdpi.com/2075-4418/15/5/633/pdf YÖKSİS SJR Q2 JCR Q1
  19. 2025 Evaluation of Antifungal Treatment Strategies in Febrile Neutropenic Episodes of High-Risk Hematologic Malignancies: A Single Center Retrospective Study Turkish Journal of Internal Medicine DOI 10.46310/tjim.1602618 YÖKSİS OpenAlex 1.7%
  20. 2025 Immunonutritional profiling for prognostic assessment in diffuse large b-cell lymphoma: an initial evaluation of the C-reactive Protein-Albumin-Lymphocyte (CALLY) Index Health Sciences Medicine DOI 10.32322/jhsm.1770811 YÖKSİS TR Index OpenAlex 30.3%

← Akademisyenlere dön